As compared with vehicle-injected mice, β-GalCer–treated animals had quicker onset of disease ( P < 0.005) and increased mean maximum and cumulative clinical scores, although differences for the latter disease parameters did not reach statistical significance.
← all excerpts
Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.
1
—
—